Utrophin News and Research

RSS
Utrophin, also known as UTRN, is a human gene. Utrophin was found during research into Duchenne's muscular dystrophy.
New study indicates novel therapies for Duchenne muscular dystrophy

New study indicates novel therapies for Duchenne muscular dystrophy

Small molecules may open the door to new therapies for Duchenne muscular dystrophy

Small molecules may open the door to new therapies for Duchenne muscular dystrophy

Researchers investigate biochemical, physiological characteristics of facial and extraocular muscles

Researchers investigate biochemical, physiological characteristics of facial and extraocular muscles

New gene therapy approach to treating DMD reduces symptoms, extends life span in mouse model

New gene therapy approach to treating DMD reduces symptoms, extends life span in mouse model

Kay E. Davies named recipient of ASHG's 2015 William Allan Award

Kay E. Davies named recipient of ASHG's 2015 William Allan Award

Study combines induced pluripotent stem cell technology and genetic correction to treat DMD

Study combines induced pluripotent stem cell technology and genetic correction to treat DMD

Research on dystrophin gene sequence could lead to treatments for Duchenne muscular dystrophy

Research on dystrophin gene sequence could lead to treatments for Duchenne muscular dystrophy

MDA announces $13.7M in grants to 40 new muscular dystrophy research initiatives

MDA announces $13.7M in grants to 40 new muscular dystrophy research initiatives

Biglycan protein offers potential therapy for muscular dystrophy

Biglycan protein offers potential therapy for muscular dystrophy

Brown grants exclusive intellectual property license to Tivorsan Pharmaceuticals

Brown grants exclusive intellectual property license to Tivorsan Pharmaceuticals

BioMarin reports $0.5 million GAAP net loss for second-quarter 2010

BioMarin reports $0.5 million GAAP net loss for second-quarter 2010

BioMarin completes BMN 195 Phase 1 clinical trial for Duchenne muscular dystrophy

BioMarin completes BMN 195 Phase 1 clinical trial for Duchenne muscular dystrophy

Researchers identify promising gene therapy for DMD

Researchers identify promising gene therapy for DMD

End Duchenne Day to be celebrated on June 26, 2010: PPMD

End Duchenne Day to be celebrated on June 26, 2010: PPMD

BioMarin Pharmaceutical reports GAAP net income of $4.7M for fourth-quarter 2009

BioMarin Pharmaceutical reports GAAP net income of $4.7M for fourth-quarter 2009

BioMarin Pharmaceutical commences BMN 195 Phase 1 clinical study for DMD

BioMarin Pharmaceutical commences BMN 195 Phase 1 clinical study for DMD

Research shows exon-skipping drug may prove effective for treating Duchenne muscular dystrophy

Research shows exon-skipping drug may prove effective for treating Duchenne muscular dystrophy

New therapy shows potential for treating Duchenne muscular dystrophy

New therapy shows potential for treating Duchenne muscular dystrophy

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

New target for muscular dystrophy drug therapy

New target for muscular dystrophy drug therapy